EMBX (EMBX) Stock Price & Analysis
EMBX (EMBX) fell 0.14% to USD 50.94 as of September 8, 2026 at 21:55 UTC, according to Nexqual real-time market data.
EMBX last closed at USD 51.01; the session ranged USD 50.91–51.02 on volume of 12,210 shares. Market capitalization is —, with a 52-week range of USD 49.42–54.61 (PCX). Source: Nexqual, September 8, 2026 at 21:55 UTC.
Key Statistics (as of September 8, 2026 at 21:55 UTC)
| Price | USD 50.94 |
|---|---|
| Change | ▼ 0.14% (down) |
| Previous Close | USD 51.01 |
| Open | USD 51 |
| Day Range | USD 50.91 – 51.02 |
| 52-Week Range | USD 49.42 – 54.61 |
| Volume | 12,210 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (EMBX)
Nexqual's technical model rates EMBX "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 21:55 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 45.6 (neutral) |
| vs SMA50 | Below (USD 51.12) |
| MACD | -0.06 (negative) |
Financial Health Score (EMBX)
Nexqual rates EMBX's overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 21:55 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GCOR | Goldman Sachs Access U.S. Aggre | USD 40.28 | ▼ 0.05% |
| DUSA | Davis Select U.S. Equity ETF | USD 56.82 | ▼ 0.87% |
| EMIS | Emmis Acquisition Corp. | USD 10.25 | ▲ 0% |
| GTOP | Goldman Sachs Technology Opport | USD 48.85 | ▲ 0.8% |
| NTII | NEUROBIOLOGICAL TECHNOLOGIES IN | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 21:55 UTC. This page is informational and not investment advice.